British Journal of Pharmacology

Papers
(The H4-Index of British Journal of Pharmacology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
425
Issue Information347
324
Issue Information248
213
Palbociclib blocks neutrophilic phosphatidylinositol 3‐kinase activity to alleviate psoriasiform dermatitis181
155
The potential for biased signalling in the P2Y receptor family of GPCRs151
Correction to ‘Stabilisation of PRCP by deubiquitinase‐targeting chimera (DUBTAC) to replenish autophagy for ameliorating pathological cardiac hypertrophy’150
Correction to “Melatonin epigenetic potential on testicular functions and fertility profile in varicocele rat model is mediated by silent information regulator 1”134
EXPRESSION OF CONCERN: Nitropravastatin Stimulates Reparative Neovascularisation and Improves Recovery from Limb Ischaemia in Type‐1 Diabetic Mice123
Dual action of macrophage miR‐204 confines cyclosporine A‐induced atherosclerosis122
Pharmacological inhibition of hydroxysteroid 11‐beta dehydrogenase type 1 (11‐βHSD1) after myocardial infarction preserves cardiac function in a translational mini‐pig model102
Issue Information91
Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity89
Justifying and reporting the use of severe stress in experiments that use animals86
Clinical‐data‐driven pharmacological framework in liver disease: From liver cirrhosis to hepatocellular carcinoma73
Opportunities of patient‐derived organoids in drug development71
Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer69
Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin68
Cardiotoxicity of BRAF/MEK inhibitors66
Chemosensory signalling in human sperm is controlled by Ca2+ influx via CatSper and Ca2+ clearance via plasma membrane Ca2+ ATPases66
The β 2 ‐adrenoceptor agonist formoterol attenuates hallmarks of adrenal Cushing's syndrome66
Graph‐based algorithms to dissect long‐distance water‐mediated H‐bond networks for conformational couplings in GPCRs62
Down‐regulation of M 6 A demethylase ALKBH5 facilitates morphine tolerance via SGK1 in mice57
Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors56
Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction55
Gβγ subunit signalling underlies neuropeptide Y‐stimulated vasoconstriction in rat mesenteric and coronary arteries55
GPR84 in physiology—Many functions in many tissues55
The fast‐dissociating D 2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment53
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline51
6‴‐Feruloylspinosin ameliorates pressure overload‐induced heart failure with comorbid insomnia through the activation of RORα50
Novel therapeutic approaches to target neurodegeneration48
Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning48
Allosterism in the adenosine A2A and cannabinoid CB2 heteromer47
Activation of peripheral cannabinoid receptors by CB13 attenuates burn injury–induced chronic pain through TRP channel modulation45
Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury43
Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review42
Publication fraud in the era of generative artificial intelligence42
Biphasic effect of nicotine on glutamatergic activity in male mouse brain42
Exploring pharmacological inhibition of Gq/11 as an analgesic strategy42
The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors42
0.089030981063843